New Ray Medicine International Holding Limited (HKG:6108)

HKG:6108 Revenue

In the year 2025, New Ray Medicine International Holding had annual revenue of 130.37M HKD with 38.78% growth. New Ray Medicine International Holding had revenue of 85.67M in the half year ending December 31, 2025, with 347.66% growth.

• Revenue: 130.37M
• Revenue Growth: +38.78%
• P/S Ratio: 0.32
• Revenue / Employee: 4.35M
• Employees: 30
• Market Cap: 41.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	130.37M	36.43M	38.78%
Dec 31, 2024	93.95M	43.79M	87.31%
Dec 31, 2023	50.15M	-39.62M	-44.13%
Dec 31, 2022	89.77M	-245.61M	-73.23%
Dec 31, 2021	335.38M	202.17M	151.76%